Anhui Anke BioTech Group Financial Flexibility Index
Anhui Anke BioTech Group financial flexibility index. Anhui Anke BioTech Group (300009) has a Financial Flexibility Index of 0.35x as of September 2025. Free cash flow of CN¥262.14 Million (operating CF CN¥240.51 Million minus capex CN¥21.63 Million) represents 0% of total liabilities (CN¥755.64 Million). See Anhui Anke BioTech Group (300009) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Anhui Anke BioTech Group (2006–2025)
Financial flexibility index of Anhui Anke BioTech Group from 2006 to 2025. Historical Financial Flexibility Index trend for Anhui Anke BioTech Group across 20 annual periods. Check 300009 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Anhui Anke BioTech Group Financial Flexibility Index by Year (2006–2025)
Anhui Anke BioTech Group financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Anhui Anke BioTech Group. For the full cash flow conversion analysis, see cash efficiency ratio of Anhui Anke BioTech Group.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.22x | CN¥990.11 Million | CN¥863.22 Million | CN¥811.30 Million | ▲ +27.0% |
| 2024 | 0.96x | CN¥802.60 Million | CN¥685.37 Million | CN¥835.41 Million | ▼ -14.8% |
| 2023 | 1.13x | CN¥1.15 Billion | CN¥952.97 Million | CN¥1.02 Billion | ▼ -17.8% |
| 2022 | 1.37x | CN¥1.17 Billion | CN¥698.98 Million | CN¥855.17 Million | ▲ +45.2% |
| 2021 | 0.94x | CN¥723.40 Million | CN¥592.17 Million | CN¥765.52 Million | ▼ -6.0% |
| 2020 | 1.01x | CN¥603.32 Million | CN¥464.80 Million | CN¥600.29 Million | ▲ +9.7% |
| 2019 | 0.92x | CN¥482.10 Million | CN¥295.63 Million | CN¥526.19 Million | ▼ -5.7% |
| 2018 | 0.97x | CN¥501.21 Million | CN¥287.49 Million | CN¥515.86 Million | ▲ +16.3% |
| 2017 | 0.84x | CN¥412.40 Million | CN¥280.63 Million | CN¥493.73 Million | ▲ +37.6% |
| 2016 | 0.61x | CN¥327.18 Million | CN¥258.01 Million | CN¥539.04 Million | ▼ -50.7% |
| 2015 | 1.23x | CN¥155.69 Million | CN¥118.73 Million | CN¥126.48 Million | ▼ -11.1% |
| 2014 | 1.38x | CN¥196.72 Million | CN¥108.68 Million | CN¥142.11 Million | ▲ +45.6% |
| 2013 | 0.95x | CN¥84.85 Million | CN¥53.21 Million | CN¥89.21 Million | ▼ -38.8% |
| 2012 | 1.55x | CN¥113.22 Million | CN¥53.80 Million | CN¥72.91 Million | ▲ +3.5% |
| 2011 | 1.50x | CN¥89.72 Million | CN¥7.18 Million | CN¥59.77 Million | ▲ +72.2% |
| 2010 | 0.87x | CN¥58.61 Million | CN¥47.43 Million | CN¥67.25 Million | ▼ -20.1% |
| 2009 | 1.09x | CN¥51.21 Million | CN¥38.67 Million | CN¥46.95 Million | ▲ +148.9% |
| 2008 | 0.44x | CN¥32.57 Million | CN¥26.04 Million | CN¥74.32 Million | ▼ -1.9% |
| 2007 | 0.45x | CN¥44.42 Million | CN¥35.10 Million | CN¥99.46 Million | ▲ +43.7% |
| 2006 | 0.31x | CN¥32.24 Million | CN¥29.66 Million | CN¥103.72 Million | — |